Distinct glomerular disease association after vaccination with BNT162b2 and mRNA-1273: a VigiBase analysis

Andreas Kronbichler; Se Yong Jung; Min Seo Kim; Jae Il Shin

doi:10.1016/j.kint.2021.11.013

Related publications

Article2024

Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial

Margaretha Prins, Geert V.T. Roozen, Cilia R. Pothast, Wesley Huisman, Rob van Binnendijk, Gerco den Hartog, Vincent P. Kuiper, Corine Prins, Jacqueline J. Janse, Olivia A. C. Lamers, Jan Pieter R. Koopman, Annelieke C. Kruithof, Ingrid M. C. Kamerling, Romy C. Dijkland, Alicia C. de Kroon, Shohreh Azimi, Mariet C.W. Feltkamp, Marjan Kuijer, Simon P. Jochems, Mirjam H.M. Heemskerk, Frits R. Rosendaal, Meta Roestenberg, Leo G. Visser, Anna H.E. Roukens

npj Vaccines

Article2022

Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers

Elena Azzolini, Riccardo Levi, Riccardo Sarti, Chiara Pozzi, Maximiliano Mollura, Alberto Mantovani, María Rescigno

Article2022

Predictive Factors for Neutralizing Antibody Levels Nine Months after Full Vaccination with BNT162b2: Results of a Machine Learning Analysis

Dimitris Papadopoulos, Ioannis Ntanasis‐Stathopoulos, Maria Gavriatopoulou, Zoi Evangelakou, Panagiotis Malandrakis, Maria S. Manola, Despoina D. Gianniou, Efstathios Kastritis, Ioannis P. Trougakos, Meletios A Dimopoulos, Vangelis Karalis, Evangelos Terpos

Article2024

Coagulation and inflammatory response after intramuscular or intradermal mRNA-1273 SARS-CoV-2 vaccine: secondary analysis of a randomized trial

Willian van Dijk, Margaretha Prins, Anna H.E. Roukens, Geert V.T. Roozen, Meta Roestenberg, Leo G. Visser, Astrid van Hylckama Vlieg, Frits R. Rosendaal

Research and Practice in Thrombosis and Haemostasis

Letter2021

Why two doses of the BNT162b2 mRNA COVID-19 vaccine? A different strategy to speed up the vaccination process: single-dose of the BNT162b2 mRNA COVID-19 and other vaccines

Carlo La Vecchia, Stefano Centanni, Alberto Giovanni Gerli